Cary Street Partners Investment Advisory LLC Astrazeneca PLC Transaction History
Cary Street Partners Investment Advisory LLC
- $173 Billion
- Q1 2025
A detailed history of Cary Street Partners Investment Advisory LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cary Street Partners Investment Advisory LLC holds 3,178 shares of AZN stock, worth $225,510. This represents 0.13% of its overall portfolio holdings.
Number of Shares
3,178
Previous 2,337
35.99%
Holding current value
$225,510
Previous $153 Million
52.55%
% of portfolio
0.13%
Previous 0.1%
Shares
14 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.05 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.89 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.53 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.26 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.22 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $220B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...